Cantitate/Preț
Produs

Cancer Targeting Therapies: Conventional and Advanced Perspectives: Drugs and the Pharmaceutical Sciences

Editat de Muhammad Yasir Ali, Shazia Bukhari
en Limba Engleză Hardback – 30 sep 2023
This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis. It incudes conventional and advanced cancer therapies ranging from oral and parenteral preparations to advanced fabricated systems such as nanoparticles, liposomes, antibodies, aptamers, poly(amidoamine) and photodynamic therapies. The preparation and mechanisms of molecular targeting of cancer are presented and the authors focus on a diverse audience including undergraduates and research students.
Features
  • Timely coverage of changes in process control technology for the phamaceutical industry, a dynamic area in terms of products and manufacturing processes
  • Provides an update on the unique requirements of these industries and how they differ from others, for example the microelectronics or specialized chemicals industries
  • Draws on the author's vast experience in the field of industrial hygiene and hazardous materials
  • Presents a collection of unique situations in which industrial hygiene was implemented to resolve a variety of scenarios and did not interfere with quality issues
  • Addresses current topics relating to industry evolution such as migration of therapies to higher potency, RiskMAP, new modalities in medicines and treatments, large molecule therapeutics and conjugates
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 27075 lei  43-57 zile
  Taylor & Francis Ltd. – 19 dec 2024 27075 lei  43-57 zile
Hardback (1) 54576 lei  22-36 zile +3078 lei  5-11 zile
  CRC Press – 30 sep 2023 54576 lei  22-36 zile +3078 lei  5-11 zile

Din seria Drugs and the Pharmaceutical Sciences

Preț: 54576 lei

Preț vechi: 59322 lei
-8% Nou

Puncte Express: 819

Preț estimativ în valută:
10445 10849$ 8676£

Carte disponibilă

Livrare economică 13-27 ianuarie 25
Livrare express 27 decembrie 24 - 02 ianuarie 25 pentru 4077 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781032426259
ISBN-10: 103242625X
Pagini: 312
Ilustrații: 28 Tables, black and white; 34 Line drawings, color; 2 Line drawings, black and white; 1 Halftones, color; 35 Illustrations, color; 2 Illustrations, black and white
Dimensiuni: 178 x 254 x 19 mm
Greutate: 0.73 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Drugs and the Pharmaceutical Sciences


Public țintă

Postgraduate, Professional Practice & Development, and Undergraduate Advanced

Cuprins

    1. History of Cancer Therapies
    2. Cancer and Carcinogens
    3. Causes of Death from Cancer
    4. Passive Targeting
    5. Cancer Active Targeting Strategies
      Conventional Cancer Therapies

    6. Oral Anticancer Therapies
    7. Parenteral Anticancer Therapies
      Advanced Cancer Therapies

    8. The Advent of Micro and Nano-spheres for Cancer Treatment
    9. The Emergence of Liposomes in Cancer Therapy
    10. Niosomes-Based Anticancer Therapies
    11. Solid Lipid Nanoparticles-Based Anticancer Therapies
    12. Mesoporous Nanoparticles-Based Anticancer Therapies
    13. Antibody-Based Cancer Therapies
    14. Aptamer-Based Anticancer Therapies
    15. Polyamidoamines-Based Anticancer Therapies
    16. Photodynamic Therapies for Cancer Treatment

Notă biografică

Dr. Muhammad Yasir Ali
My pharmacy career started back in 2002 as a graduate student, leading to the achievement of a graduate and then a master's degree in Pharmaceutical Technology in 2009. Nevertheless, with my thirst for knowledge as a student and researcher, an in-line experience in production and quality control in Roche Pakistan helped me in knowing the ropes of the subject.
Later on, I joined the university of Lahore as a faculty member and taught different courses to pharmacy graduates, especially pharmaceutical technology. In 2011 after joining my current job, I kept on teaching and indulged myself in research which is still going on, meanwhile, I got my doctorate (Pharmaceutical Technology) from Germany.
I have more than 30 research publications, one research project, practical application of pharmacy knowledge in the form of different marketed products, several book chapters, and one book as editor in my research basket. I got chances of presenting research papers and scientific lectures in different organizations in Germany, USA, UK, and Pakistan.
Dr. Shazia Bukhari
I completed my undergraduate studies from the Bahuddin Zakariya University, Multan (1998-2001) and my M.Phil. studies from the Department of Biochemistry, University of Agriculture, Faisalabad Pakistan (2001-2003). Then I continued higher studies in Punjab University and earned Ph.D. degree in Biochemistry (2005-2009).
I started my career at Hi-Tech Lab, University of Agriculture, Faisalabad (2003 – 2004). Then I joined Center for Agricultural Biochemistry and Biotechnology (CABB), University of Agriculture, Faisalabad as Research Officer/Lecturer (2004-2011). Then I joined Government College University as Assistant Professor (2011-2014). I was promoted to Associate Professor (2014-2019 and Professor (2019 to date) in the Department of Biochemistry of the same university.
My research interest focuses on the exploration of indigenous flora for treatment of various diseases, based on an understanding of the mechanisms underlying the successful interactions between the plant components and disease. For this purpose, we are now using computational tools to correlate the laboratory findings with computer modeling. I am also working to enhance resistance of wheat (Triticum aestivum) against fungus diseases like rust. For this purpose, we have been transforming rust resistance and Pathogenesis-Related genes, isolated from local verities, and transform into high yielding wheat commercial varieties. I have screened and characterized nine novel genes relating rust resistance and pathogenesis related and deposited in gene bank. I am currently running two projects for achieving this goal approved by HEC: 3.679,655 million) as PI and 2nd approved by Technology Development Funds. HEC (13.609 million) as PI.

Descriere

This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis.